Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 20/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16876581 | 0.93 | PARP1 (1.00) | PARP1 | |
| SCHEMBL18241704 | 0.91 | PARP1 (0.81) | PARP1 | |
| SCHEMBL18255514 | 0.88 | PARP1 (0.78) | PARP1 | |
| SCHEMBL20571333 | 0.88 | PARP1 (0.80) | PARP1 | |
| SCHEMBL6200605 | 0.88 | PARP1 (0.77) | PARP1 | |
| SCHEMBL7161541 | 0.88 | PARP1 (0.91) | PARP1 | |
| SCHEMBL20627064 | 0.88 | PARP1 (0.80) | PARP1 | |
| SCHEMBL7165788 | 0.87 | PARP1 (1.00) | PARP1 | |
| SCHEMBL20571032 | 0.87 | PARP1 (0.72) | PARP1 | |
| SCHEMBL18255497 | 0.86 | PARP1 (0.75) | PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3424909-A1 | A POLY (ADP-RIBOSE) POLYMERASE-1 (PARP-1) INHIBITOR AND USES THEREFOR | Washington University (US) | 2019-01-09 | — | — | EP | disclosed |
| US-9993570-B2 | Radiolabeled tracers for poly (ADP-ribose) polymerase-1 (PARP-1), methods and uses therefor | WASHINGTON UNIVERSITY (US) | 2018-06-12 | — | — | US | disclosed |
| EP-1208104-B1 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES | AGOURON PHARMA (US) | 2005-01-19 | — | — | EP | disclosed |
| US-6548494-B1 | 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases | AGOURON PHARMACEUTICALS, INC. | 2003-04-15 | — | — | US | disclosed |